Swiss HLG Conference 2026

“Partner or Perish”

How Collaboration Can Sustain Healthcare Innovation in a Fragmenting World

In an era where the foundations of biotech innovation are being fundamentally reshaped - driven by China’s meteoric rise, rapidly evolving U.S. policy dynamics, and tightening capital markets for emerging players - the stakes for dealmaking have never been higher. Add to this the looming patent cliffs for cornerstone therapies, and the message is clear: sustained growth demands strategic reinvention.

Collaboration is no longer an option; it is the lifeline for resilience and global competitiveness.

Unlock Resilience, Acquire Growth
Join us in Montreux for the flagship event that equips you to navigate this fractured global landscape. Across three dynamic verticals - focused on the US, Europe, and Asia - we move beyond abstract challenges to deliver concrete solutions.

This conference is your opportunity to:

• Acquire Cutting-Edge Expertise: Dive into advanced negotiation strategies, master innovative deal structures, and learn how to manage the complex governance of multinational alliances.
• Bridge Strategic Divides: Gain crucial, actionable intelligence on how different regional dynamics (from FDA policy shifts to China domestic innovation models) impact your licensing and M&A pipeline.
• Invest in Your Network: Connect with 200+ senior BD leaders, M&A executives, and Venture Capital experts. The Swiss HLG provides the unique environment needed to forge the trusted relationships that underpin billion-dollar deals.

Don’t just adapt to the new world order - thrive in it. Register now to discover why partnership is the definitive strategy for sustaining healthcare innovation.

Join us for 2,5 days of thought-provoking discussions, valuable insights, and exceptional networking opportunities with industry leaders and peers. The conference will provide a unique platform to exchange ideas, foster collaborations, and shape the future of healthcare and life sciences together.